Furthermore, HIF-3α has been implicated in the progression of pancreatic cancer by directly binding the promoters of RHOC and ROCK1 and transactivating the RhoC-ROCK1 pathway in cancer cells that overexpress HIF3A [41]. The gene discussed is HIF3A; the disease is pancreatic neoplasm.